Johnson & Johnson requests emergency authorization for Covid vaccine

J&J subsidiary Janssen Biotech "has submitted an application to the US Food and Drug Administration (FDA) requesting Emergency Use Authorization (EUA) for its investigational single-dose Janssen COVID-19 vaccine candidate," a company statement read.

from International-News-Economic Times https://ift.tt/2MTC5Vg
via IFTTT

SHARE